Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice.
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocy
[Remyelination strategy for multiple sclerosis].
[Factors associated to the work situation of patients with multiple sclerosis].
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study.
Exogenous Adult Post Mortem Neural Precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury.
Histamine h3 receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.
Preface: Perspectives of an MS Researcher.
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.
Making myelin basic protein -from mRNA transport to localized translation.
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.
There is much to be learnt about the costs of multiple sclerosis in Latin America.
Epstein-Barr virus in oral shedding of children with multiple sclerosis.
Immunology for understanding the pathogenesis of multiple sclerosis.
Caregiving in multiple sclerosis.
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms.
Remyelination strategies in multiple sclerosis: a critical reflection.
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS).
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.
Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials.
Intrinsic third ventricular craniopharyngioma: A case report.
CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study.
Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Fatigue in multiple sclerosis: a look at the role of poor sleep.
Pages
« first
‹ previous
…
604
605
606
607
608
609
610
611
612
…
next ›
last »